Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

OrthoPediatrics (KIDS) Price & Analysis

KIDS Stock Chart & Stats

$30.87-$0.65(-2.06%)
At close: 4:00 PM EDT
$20$25$303 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$30.77 - $31.93
52-Week Range
$14.42 - $32.62
Previous Close
$31.52
Volume
117.04K
Average Volume (3M)
300.41K
Market Cap
$806.03M
Enterprise Value
$598.83M
Total Cash (Recent Filing)
$44.23M
Total Debt (Recent Filing)
$98.36M
Price to Earnings (P/E)
―
Beta
0.61
Next Earnings
Mar 10, 2027
EPS Estimate
-0.21
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth And Gross Margins

Sustained revenue expansion alongside consistently high gross margins indicates strong demand for the pediatric-focused portfolio and meaningful product economics. This combination gives OrthoPediatrics resources to invest in commercial expansion, innovation, and surgeon adoption while supporting scalable growth.

Specialized Market Position And Product Adoption

Deep adoption across children's hospitals and surgeon networks can reinforce OrthoPediatrics' specialized market position. Products that achieve broad hospital penetration may increase recurring implant utilization, strengthen contracting leverage, and help pull through related legacy products over multiple years.

Improving EBITDA And Cash Flow Outlook

The combination of improving EBITDA, positive quarterly free cash flow, and a stated path toward sustained positive FCF suggests operating leverage is beginning to emerge. If execution continues, stronger internal cash generation could reduce funding pressure and support continued product and set investment.

Bears Say

Persistent Net And Operating Losses

Despite strong sales growth and narrowing losses, the company has not yet demonstrated durable earnings power. Persistent operating and net losses can constrain internally funded investment, leave profitability sensitive to expense growth, and make future performance dependent on continued operating leverage.

Unproven Cash Flow Consistency

The recent shift to positive operating and free cash flow is encouraging but follows multiple years of negative operating cash flow. Limited consistency means cash generation may not yet reliably fund growth investments, set deployments, and operating needs without execution remaining strong.

Delayed Commercialization Of Growth Products

The timing of major product launches creates a multi-quarter gap between investment and meaningful revenue contribution. Delayed commercialization could defer expected growth, margin, and cash-flow benefits, leaving near-term results more reliant on the existing portfolio and continued execution in current channels.

OrthoPediatrics News

KIDS FAQ

What was OrthoPediatrics’s price range in the past 12 months?
OrthoPediatrics lowest stock price was $14.42 and its highest was $32.62 in the past 12 months.
What is OrthoPediatrics’s market cap?
OrthoPediatrics’s market cap is $806.03M.
When is OrthoPediatrics’s upcoming earnings report date?
OrthoPediatrics’s upcoming earnings report date is Mar 10, 2027 which is in 129 days.
How were OrthoPediatrics’s earnings last quarter?
OrthoPediatrics released its earnings results on Oct 27, 2026. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.214 by -$0.036.
Is OrthoPediatrics overvalued?
According to Wall Street analysts OrthoPediatrics’s price is currently Overvalued.
Does OrthoPediatrics pay dividends?
OrthoPediatrics does not currently pay dividends.
What is OrthoPediatrics’s EPS estimate?
OrthoPediatrics’s EPS estimate is -0.21.
How many shares outstanding does OrthoPediatrics have?
OrthoPediatrics has 26,110,476 shares outstanding.
What happened to OrthoPediatrics’s price movement after its last earnings report?
OrthoPediatrics reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.214. Following the earnings report the stock price went up 29.303%.
Which hedge fund is a major shareholder of OrthoPediatrics?
Currently, no hedge funds are holding shares in KIDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology